זיפאדהרה 300 מ"ג Ізраїль - іврит - Ministry of Health

זיפאדהרה 300 מ"ג

eli lilly israel ltd - olanzapine 300 mg - powder for suspension for injection - olanzapine - zypadhera is indicated for the treatment of schizophrenia.the use of zypadhera is limited to patients who have been diagnosed as non-compliant regarding taking prescribed medicines and as a consequence are prone to outbursts of psychotic episodes .zypadhera is not to be used in patients whose condition is adequately controlled with oral zyprexa .zypadhera is available only through a restricted program which will be conducted according to zypadhera eu risk management plan.for a patient to receive treatment, the prescribers , injection administrators, pharmacists and patients must all be trained on the appropriate elements of the zypadhera risk management plan. the zypadhera risk management plan has been developed to enable the safe use of zypadhera in patients, including the management of those patients who develop post-injection delirium and sedation syndrome. in addition to mandating label language around this risk, this plan includes education and training activities to the following target audience as appr

זיפאדהרה 405 מ"ג Ізраїль - іврит - Ministry of Health

זיפאדהרה 405 מ"ג

eli lilly israel ltd - olanzapine as pamoate monohydrate 405 mg - powder for suspension for injection - olanzapine - zypadhera is indicated for the treatment of schizophrenia.the use of zypadhera is limited to patients who have been diagnosed as non-compliant regarding taking prescribed medicines and as a consequence are prone to outbursts of psychotic episodes .zypadhera is not to be used in patients whose condition is adequately controlled with oral zyprexa .zypadhera is available only through a restricted program which will be conducted according to zypadhera eu risk management plan.for a patient to receive treatment, the prescribers , injection administrators, pharmacists and patients must all be trained on the appropriate elements of the zypadhera risk management plan. the zypadhera risk management plan has been developed to enable the safe use of zypadhera in patients, including the management of those patients who develop post-injection delirium and sedation syndrome. in addition to mandating label language around this risk, this plan includes education and training activities to the following target audience as appr

אסיול 10 מג2 מל Ізраїль - іврит - Ministry of Health

אסיול 10 מג2 מל

teva pharmaceutical industries ltd, israel - diazepam - תמיסה להזרקה - diazepam 10 mg / 2 ml - diazepam - diazepam - symptomatic relief of tension and anxiety either alone or when associated with stressful situations. psychoneurotic states manifested by tension, anxiety, apprehension, fatigue and depressive symptoms. in acute alcohol withdrawal, assival may be useful in the symptomatic relief of tremor, impending or acute delirium tremens and hallucinosis. assival is a useful adjunct in the relief of skeletal muscle spasm, spasticity, stiffman syndrome and tetanus. when used intravenously, assival injection is a useful adjunct in status epilepticus and severe recurrent convulsive seizures. as premedication in patients undergoing surgical procedures (the intramuscular route is preferred) or in patients undergoing cardioversion (when the intravenous route is preferred).

לוריוון Ізраїль - іврит - Ministry of Health

לוריוון

dexcel ltd, israel - lorazepam - טבליה - lorazepam 1 mg - lorazepam - lorazepam - anxiety and tension.

אפקסור XR 150 Ізраїль - іврит - Ministry of Health

אפקסור xr 150

pfizer pfe pharmaceuticals israel ltd - venlafaxine as hydrochloride - קפסולות בשחרור נרחב - venlafaxine as hydrochloride 150 mg - venlafaxine - venlafaxine - for the treatment of depression. maintenance of recurrent depression. generalized anxiety disorder (gad) - short term and long-term. social anxiety disorder (sad).

איקסל 25 מג Ізраїль - іврит - Ministry of Health

איקסל 25 מג

perrigo israel agencies ltd - milnacipran hydrochloride - קפסולות - milnacipran hydrochloride 25 mg - milnacipran - milnacipran - treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old.

יסקרטה Ізраїль - іврит - Ministry of Health

יסקרטה

gilead sciences israel ltd - axicabtagene ciloleucel - axicabtagene ciloleucel